IDenta Corp. (IDTA)
USD 0.36
(0.0%)
USD 0.36
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.52 Million USD | -1.9% |
| 2022 | 1.55 Million USD | 26.81% |
| 2021 | 1.22 Million USD | 15.91% |
| 2020 | 1.06 Million USD | 56.45% |
| 2019 | 677.95 Thousand USD | 17.9% |
| 2018 | 575.03 Thousand USD | 28.14% |
| 2017 | 448.75 Thousand USD | -19.53% |
| 2016 | 557.69 Thousand USD | 1.81% |
| 2015 | 547.75 Thousand USD | -21.93% |
| 2014 | 701.66 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.66 Million USD | 1.15% |
| 2024 Q1 | 1.64 Million USD | 7.49% |
| 2023 Q4 | 1.52 Million USD | 24.19% |
| 2023 Q1 | 1.47 Million USD | -5.34% |
| 2023 Q2 | 1.33 Million USD | -9.74% |
| 2023 FY | 1.52 Million USD | -1.9% |
| 2023 Q3 | 1.23 Million USD | -7.55% |
| 2022 Q3 | 1.12 Million USD | -3.36% |
| 2022 FY | 1.55 Million USD | 26.81% |
| 2022 Q1 | 1.14 Million USD | -6.82% |
| 2022 Q2 | 1.16 Million USD | 1.85% |
| 2022 Q4 | 1.55 Million USD | 38.25% |
| 2021 Q1 | 1.16 Million USD | 9.71% |
| 2021 FY | 1.22 Million USD | 15.91% |
| 2021 Q4 | 1.22 Million USD | -4.15% |
| 2021 Q3 | 1.28 Million USD | 8.09% |
| 2021 Q2 | 1.18 Million USD | 1.97% |
| 2020 Q2 | 1.13 Million USD | 56.5% |
| 2020 Q1 | 726.47 Thousand USD | 7.16% |
| 2020 Q3 | 1.06 Million USD | -5.92% |
| 2020 FY | 1.06 Million USD | 56.45% |
| 2020 Q4 | 1.06 Million USD | -0.84% |
| 2019 Q4 | 677.95 Thousand USD | -8.72% |
| 2019 Q1 | 608.96 Thousand USD | 5.9% |
| 2019 Q2 | 790.61 Thousand USD | 29.83% |
| 2019 FY | 677.95 Thousand USD | 17.9% |
| 2019 Q3 | 742.75 Thousand USD | -6.05% |
| 2018 Q2 | 518.96 Thousand USD | -5.59% |
| 2018 FY | 575.03 Thousand USD | 28.14% |
| 2018 Q4 | 575.03 Thousand USD | -4.9% |
| 2018 Q3 | 604.64 Thousand USD | 16.51% |
| 2018 Q1 | 549.66 Thousand USD | 22.49% |
| 2017 FY | 448.75 Thousand USD | -19.53% |
| 2017 Q4 | 448.75 Thousand USD | 0.0% |
| 2016 FY | 557.69 Thousand USD | 1.81% |
| 2015 FY | 547.75 Thousand USD | -21.93% |
| 2014 FY | 701.66 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -20.51% |
| Arrayit Corporation | 1 Million USD | -52.868% |
| Atlantic International Corp. | 4.43 Million USD | 65.529% |
| Biocept, Inc. | 30.87 Million USD | 95.047% |
| Bioqual, Inc. | 56.58 Million USD | 97.298% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -559.364% |
| DermTech, Inc. | 121.93 Million USD | 98.746% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.963% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 91.398% |
| iMD Companies, Inc. | 190.13 Thousand USD | -704.302% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 88.255% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 81.468% |
| InVitro International | 1.53 Million USD | 0.308% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 94.302% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -66045.112% |
| Medical Imaging Corp. | 4.19 Million USD | 63.516% |
| NovelStem International Corp. | 2.25 Million USD | 32.169% |
| Optigenex Inc. | 1.88 Million USD | 19.013% |
| PharmChem, Inc. | 2.76 Million USD | 44.703% |
| Proteome Sciences plc | 14.58 Million USD | 89.515% |
| Response Genetics, Inc | 48.88 Million USD | 96.872% |
| Rennova Health, Inc. | 20.57 Million USD | 92.567% |
| RushNet, Inc. | 6.04 Million USD | 74.713% |
| ScreenPro Security Inc. | 1.26 Million USD | -21.24% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -223.709% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -118.265% |
| Todos Medical Ltd. | 15.26 Million USD | 89.983% |